Dld Asset Management, LP Acadia Pharmaceuticals Inc Call Options Transaction History

Dld Asset Management, LP

  • $438 Million
  • Q4 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 14, 2020
SELL
$31.65 - $46.87 $6.89 Million - $10.2 Million
-217,600 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$36.21 - $51.4 $1.64 Million - $2.33 Million
-45,400 Reduced 17.26%
217,600 $9.31 Million
Q3 2019

Nov 12, 2019
BUY
$22.22 - $44.01 $5.84 Million - $11.6 Million
263,000 New
263,000 $9.46 Million

Others Institutions Holding ACAD

# of Institutions
316
Shares Held
164M
Call Options Held
855K
Put Options Held
350K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.93B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email